Hannah H. Chang

We are excited to enter into a definitive merger agreement with @frequencytx. The newly established company will focus on advancing Korro’s proprietary RNA editing platform and portfolio of RNA editing programs, including our lead AATD product candidate: rb.gy/z4mfi

A radical new way of treating type 1 diabetes keeps producing promising early data, raising hopes that a cell therapy might one day become a cure for the disease. endpts.com/vertexs-cell-t…

Proud spouse - congratulations Kyle Farh! on.ft.com/43l1byq

Congratulations to my husband Kyle Farh on the publication of what we endearingly call “the monkey papers” in our house! These four articles show their innovative work developing PrimateAI-3D, an AI algorithm that predicts disease-causing variants with unprecedented accuracy.

We couldn't be more excited to be a partner to Ray Therapeutics as they develop transformative optogenetics gene therapeutics for blinding retinal diseases. Ray Therapeutics snags $100M for optogenetics gene therapy - endpts.com/ray-therapeuti…

We couldn’t be more excited to welcome Julie to Nuvig! Thank you Pam for your leadership and fortitude. Looking forward to working with you both. nuvigtherapeutics.com/nuvig-therapeu…

Congratulations to PACT Pharma on this bold and innovative work. nature.com/articles/d4158…

Congrats Akouos! investors.akouos.com/news-releases/…

@nuvigtx @novoholdings @bmsnews @digitalisvc @MissionBioCap We couldn’t be more thrilled to be a partner to Nuvig and our esteemed investor colleagues in this exciting new endeavor.

We are excited to announce our launch today! We are developing novel immune therapeutics for chronic inflammatory and #autoimmunediseases. Thank you to our investors! @novoholdings, Platanus, @bmsnews, @digitalisvc, and @MissionBioCap nuvigtherapeutics.com/nuvig-launches… #biotech #BayArea

Always insightful - a must read! According to @SVB_Financial’s annual report, healthcare venture investment and fundraising both hit record highs in 2021 bit.svb.com/3t2n0DA #SVBHealthcare @jonnysvb

Such exciting news! Hats off to the Semma / Vertex teams. nytimes.com/2021/11/27/hea…

Vertex Shares "Unprecedented" Results in Early-Stage Type 1 Diabetes Trial | BioSpace biospace.com/article/vertex… #jobs

Inipharm to Present Data Showing Potential of Small Molecule Inhibitors of HSD17B13 to Combat Liver Fibrosis at AASLD’s The Liver Meeting | Business Wire businesswire.com/news/home/2021…

@AlexHarding7 I agree and just keep this in mind: basically all adults are potty trained, which means you are going through a process that has ~100% success rate. Imagine if that were true for therapeutics R&D. Hang in there!

Status update, bc I’m sure people find this fascinating: We’re through 12 pairs of underwear and 7 juice boxes. Some may think that’s a sign things aren’t going well, but I prefer to think of it as lots of learning opportunities.

Day 1 of potty training today. #prayforme

Korro Bio Appoints Vineet Agarwal as Chief Financial Officer | Business Wire businesswire.com/news/home/2021…

Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer | BioSpace biospace.com/article/releas… #jobs

Kati Kariko Helped Shield the World From the Coronavirus nytimes.com/2021/04/08/hea…